LY262691

MedChem Express

LY262691

9

138932-35-1

Research Use Only

C22H18BrN3O2

436.30

LY262691 is a selective CCK-B antagonist with antipsychotic properties. LY262691 decreases the number of spontaneously active A9 and A10 dopamine cells and can be utilized in antipsychotic research[1].

BrC(C=C1)=CC=C1NC(N2[C@@H](C3=CC=CC=C3)[C@H](C4=CC=CC=C4)C(N2)=O)=O

12352200